Mertens, D., S. Wolf, P. Schroeter, C. Schaffner, H. Dohner, S. Stilgenbauer and P. Lichter (2002). "Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia." Blood 99(11): 4116-21. IF 9.782
Wolf, S., D. Mertens,
C.
Schaffner, C. Korz, H. Dohner, S. Stilgenbauer and P. Lichter (2001).
"B-cell neoplasia associated gene with multiple splicing (BCMS): the
candidate B-CLL gene on 13q14 comprises more than 560 kb covering all
critical regions."
Hum
Mol Genet 10(12):
1275-85. IF 7.801
Philippen, A., Diener, S., Zenz, T., Doehner, H., Stilgenbauer, S., Mertens, D. "SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)", Brithish Journal of Haematology, in press, IF 4.478
Bhattacharya, N., Sarno, A., Idler, I., Fuehrer, M., Zenz, T., Doehner, H., Stilgenbauer, S., Mertens, D. "High throughput detection of NFkB activity using a sensitive oligo-based chemiluminescent ELISA", International Journal of Cancer, in press, IF 4,734
Zenz, T., Mertens, D., Kueppers, R., Doehner, H., Stilgenbauer, S. "From pathogenesis to treatment of chronic lymphocytic leukaemia.", Nature Reviews Cancer, in press, IF 30.762 (review article)
Idler, I., Giannopoulos, K., Zenz, T., Bhattacharya, N., Nothing, M., Doehner, H., Stilgenbauer, S., Mertens, D.
"Lenalidomide treatment of chronic lymphocytic leukemia patients
reduces regulatory T-cells and induces Th17 T-helper cells." British Journal of Haematology, in press, IF 4,478
Sandra
Loeder, Thorsten Zenz, Andrea Schnaiter, Mertens, D., Dirk Winkler,
Hartmut Doehner, Klaus-Michael Debatin, Stephan Stilgenbauer, Simone
Fulda (2009): Small molecule XIAP inhibitors
act in concert with TRAIL to overcome apoptosis resistance in chronic
lymphocytic leukemia, Cancer Research, in press, IF 7,514
Zenz, T., S. Habe, T. Denzel, J. Mohr, D. Winkler, A. Buhler, A. Sarno, S. Groner, D. Mertens, R. Busch, M. Hallek, H. Dohner and S. Stilgenbauer (2009) Detailed analysis of p53 pathway defects in fludarabine-refractory CLL: dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial Blood , in press, IF 9.782
Zenz, T., Mohr, J., Edelmann, J., Sarno, A., Hoth, P., Heuberger, M., Helfrich, H., Mertens, D., Doehner, H., Stilgenbauer, S. Treatment Resistance in Chronic Lymphocytic leukemia - The role of the P53 Pathway, Leukemia & Lymphoma, in press, IF 1,559 (Review article)
Giannopoulos, K., Buehler, A., Mertens, D.,
Barth, T., Idler,
Zenz, T, Mohr, J, Eldering, E, Kater, A, van Oers, MHJ, Buehler, A, Kienle, D, Winkler, D, Duerig, J, Mertens, D, Doehner, H, Stilgenbauer, S, (2008) "MiR34a is associated with an impaired DNA damage response and poor prognostic features in CLL", Blood , in press. IF 9.782
Tschuch, C., Schulz, A., Pscherer, A., Werft, W., Benner, A., Hotz-Wagenblatt, A., Serra-Barrionuevo, L., Lichter, P., Mertens, D. (2008) "Off-target effects of siRNA specific for GFP", BMC Molecular Biology jun 24;9:60. IF 3,371
Thorsten Zenz, Daniel Mertens, Hartmut Doehner, Stephan Stilgenbauer, "Molecular diagnostics in chronic lymphocytic leukemia - Pathogenetic and clinical implications", Leukemia & Lymphoma, 49(5):864-73, (2007) IF 1,559
Claudia Kalla, Markus Scheuermann, Ina Kube, Magdalena Schlotter, Daniel Mertens, Hartmut Doehner, Stephan Stilgenbauer, Peter Lichter "Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukemia: Ecifence for a pathogenic role of NPAT, CUL5 and PPP2R1B", Eur J Cancer 43(8), 1328-35, (2007) IF 3,706
Ilka Prowatke, Frauke Devens, Axel Benner,
Elisabeth F. Gröne , D.Mertens,
Hermann-Josef Gröne, Peter Lichter, Stefan Joos, BARK1 and MYC
protein expression is associated with prostate cancer progression, Br.
J. Cancer, 96(1), 82-8, (2006) IF
4.115
Wolf, S., D. Mertens,
A. Pscherer, P. Schroeter, D. Winkler, H. J. Grone, C. Hofele, K.
Hemminki, R. Kumar, G. Steineck, H. Dohner, S. Stilgenbauer and P.
Lichter (2006). "Ala228 variant of trail receptor 1 affecting the
ligand binding site is associated with chronic lymphocytic leukemia,
mantle cell lymphoma, prostate cancer, head and neck squamous cell
carcinoma and bladder cancer." Int
J Cancer 118(7):
1831-5. IF 4.416
Kienle, D., A. Benner, A. Krober, D. Winkler, D. Mertens, A. Buhler, T. Seiler, U. Jager, P. Lichter, H. Dohner and S. Stilgenbauer (2006). "Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes." Blood 107(5): 2090-3. IF 9.782
Mertens, D., S. Wolf, C. Tschuch, C. Mund, D. Kienle, S. Ohl, P. Schroeter, F. Lyko, H. Dohner, S. Stilgenbauer and P. Lichter (2006). "Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism." Proc Natl Acad Sci U S A 103(20): 7741-6. IF 10.452
Mannherz, O., D. Mertens, M. Hahn and P. Lichter (2006). "Functional screening for proapoptotic genes by reverse transfection cell array technology." Genomics 87(5): 665-72. IF 3.840
Henrich, K. O., M. Fischer, D. Mertens, A. Benner, R. Wiedemeyer, B. Brors, A. Oberthuer, F. Berthold, J. S. Wei, J. Khan, M. Schwab and F. Westermann (2006). "Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients." Clin Cancer Res 12(1): 131-8. IF 5.623
Adamowicz, M., B. Radlwimmer, R. J. Rieker, D. Mertens, M. Schwarzbach, P. Schraml, A. Benner, P. Lichter, G. Mechtersheimer and S. Joos (2006). "Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas." Genes Chromosomes Cancer 45(9): 829-38. IF 3.937
Kalla, C., H. Nentwich, M. Schlotter, D. Mertens, K. Wildenberger, H. Dohner, S. Stilgenbauer and P. Lichter (2005). "Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes." Genes Chromosomes Cancer 42(2): 128-43. IF 3.937
Kienle, D. L., C. Korz, B. Hosch, A. Benner, D. Mertens, A. Habermann, A. Krober, U. Jager, P. Lichter, H. Dohner and S. Stilgenbauer (2005). "Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes." J Clin Oncol 23(16): 3780-92. IF 11.810
Korz, C., A. Pscherer, A. Benner, D. Mertens, C. Schaffner, E. Leupolt, H. Dohner, S. Stilgenbauer and P. Lichter (2002). "Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes." Blood 99(12): 4554-61. IF 9.782
Mertens, D., S. Wolf, P. Schroeter, C. Schaffner, H. Dohner, S. Stilgenbauer and P. Lichter (2002). "Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia." Blood 99(11): 4116-21. IF 9.782
Wolf, S., D. Mertens, C. Schaffner, C. Korz, H. Dohner, S. Stilgenbauer and P. Lichter (2001). "B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions." Hum Mol Genet 10(12): 1275-85. IF 7.801
Mertens, D., S. Wolf, L. Bullinger, S. Ohl, C. Schaffner, H. Dohner, S. Stilgenbauer and P. Lichter (2000). "BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22- p31, BCMSUN-like." Int J Cancer 88(5): 692-7. IF 4.416
Bullinger, L., E. Leupolt, C. Schaffner, D. Mertens, M. Bentz, P. Lichter, H. Dohner and S. Stilgenbauer (2000). "BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma." Leukemia 14(8): 1490-2. IF 5.810
Lammer, C., S. Wagerer, R. Saffrich, D. Mertens,
W. Ansorge and I. Hoffmann (1998). "The cdc25B phosphatase is essential
for the G2/M phase transition in human cells." J
Cell Sci 111
( Pt 16): 2445-53. IF 6.910